The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer.

Autor: Ribatti, Domenico1 (AUTHOR) domenico.ribatti@uniba.it, Solimando, Antonio Giovanni2,3 (AUTHOR) antonio.solimando@uniba.it, Pezzella, Francesco4 (AUTHOR) francesco.pezzella@ndcls.ox.ac.uk
Zdroj: Cancers. Jul2021, Vol. 13 Issue 14, p3433. 1p.
Databáze: Academic Search Ultimate